Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	The Cooper Companies	Luxottica Group	Alcon	STAAR Surgical	National Vision
Symbol	NYSE:COO	OTCMKTS:LUXTY	NYSE:ALC	NASDAQ:STAA	NASDAQ:EYE
Price Information
Current Price	$400.17	$55.80	$73.87	$114.93	$47.66
52 Week Range	Buy	N/A	Hold	Buy	Buy
MarketRank™
Overall Score	1.9	1.3	1.5	1.4	1.2
Analysis Score	2.3	0.0	2.2	1.3	1.4
Community Score	2.7	2.6	2.5	2.1	2.8
Dividend Score	1.7	1.7	0.0	0.0	0.0
Ownership Score	1.7	1.7	0.8	1.7	0.0
Earnings & Valuation Score	1.3	0.6	1.9	1.9	1.9
Analyst Ratings
Consensus Recommendation	Buy	N/A	Hold	Buy	Buy
Consensus Price Target	$384.25	N/A	$73.11	$68.50	$47.63
% Upside from Price Target	-3.98% downside	N/A	-1.03% downside	-40.40% downside	-0.07% downside
Trade Information
Market Cap	$19.64 billion	$27.07 billion	$36.21 billion	$5.50 billion	$3.87 billion
Beta	0.82	0.27	0.6	1.09	1.77
Average Volume	284,056	14,259	963,973	761,479	729,853
Sales & Book Value
Annual Revenue	$2.43 billion	$10.34 billion	$7.51 billion	$150.18 million	$1.72 billion
Price / Sales	8.09	2.62	4.80	35.64	2.25
Cashflow	$15.24 per share	$3.57 per share	$5.16 per share	$0.74 per share	$1.80 per share
Price / Cash	26.26	15.62	14.31	154.90	26.49
Book Value	$71.71 per share	$13.74 per share	$39.54 per share	$3.59 per share	$9.81 per share
Price / Book	5.58	4.06	1.87	32.01	4.86
Profitability
Net Income	$238.40 million	$1.17 billion	$-656,000,000.00	$14.05 million	$32.80 million
EPS	$9.64	$2.29	$1.89	$0.46	$0.78
Trailing P/E Ratio	83.20	24.37	N/A	604.93	1,191.80
Forward P/E Ratio	28.36	∞	39.50	216.85	69.07
P/E Growth	2.74	N/A	4.68	N/A	20.67
Net Margins	9.81%	N/A	-10.53%	5.73%	0.32%
Return on Equity (ROE)	12.79%	N/A	2.80%	8.99%	4.97%
Return on Assets (ROA)	7.20%	N/A	1.94%	7.12%	1.84%
Dividend
Annual Payout	$0.06	$0.91	N/A	N/A	N/A
Dividend Yield	0.01%	1.63%	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	0.62%	39.74%	N/A	N/A	N/A
Years of Consecutive Dividend Growth	1 Years	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.36%	0.19%	0.21%	N/A	0.75%
Current Ratio	1.27%	1.18%	2.29%	5.79%	1.56%
Quick Ratio	0.70%	0.88%	1.50%	5.25%	1.25%
Ownership Information
Institutional Ownership Percentage	95.76%	0.09%	46.52%	85.35%	N/A
Insider Ownership Percentage	1.40%	75.00%	1.52%	3.90%	2.60%
Miscellaneous
Employees	12,000	85,150	20,000	575	12,792
Shares Outstanding	49.15 million	485.06 million	488.20 million	46.57 million	81.31 million
Next Earnings Date	6/3/2021 (Estimated)	N/A	5/4/2021 (Confirmed)	5/5/2021 (Estimated)	5/6/2021 (Estimated)
Optionable	Optionable	Not Optionable	Not Optionable	Optionable	Optionable

Source	Headline
	Saluting General Raina's Vision and Courage rediff.com - April 19 at 8:11 AM
	Liberals to release federal budget with eye on managing crisis, post-pandemic growth ctvnews.ca - April 19 at 8:11 AM
	Amazon’s CEO Bezos says union push eye-opener, promises better employee treatment foxbusiness.com - April 18 at 12:24 AM
	Study finds that not all patients with elevated eye pressure need treatment to prevent vision loss news-medical.net - April 16 at 8:16 AM
	Treatment not always needed to prevent vision loss in patients with elevated eye pressure medicalxpress.com - April 15 at 2:34 PM
	BJP to hold ‘Potho Sabhas’ in and around Kolkata with eye on 40 urban seats msn.com - April 12 at 7:21 PM
	US Rep. Crenshaw Temporarily Blinded After Eye Surgery nbcnewyork.com - April 12 at 2:21 PM
	Crenshaw says he'll be 'effectively blind' and 'off the grid' for weeks after emergency eye surgery newspressnow.com - April 10 at 8:59 PM
	Crenshaw says he’ll be ‘effectively blind’ and ‘off the grid’ for weeks after emergency eye surgery abc17news.com - April 10 at 3:58 PM
	Texas Rep. Crenshaw temporarily blinded after eye surgery tulsaworld.com - April 10 at 3:58 PM
	Texas Republican Dan Crenshaw ‘virtually blind’ after eye surgery theguardian.com - April 10 at 3:58 PM
	Dan Crenshaw Announces Emergency Eye Surgery, Will Be ‘Effectively Blind’ for a Month msn.com - April 10 at 3:58 PM
	Mediaplanet Partners with Ocular Leaders of Industry to Advocate for Accessibility to Eye Health in 2021 wfmz.com - April 9 at 5:36 PM
	Diminished Hearing, Vision Together Could Be Risk Factor for Dementia usnews.com - April 7 at 6:44 PM
	J&J Vision and Menicon Tackle Myopia with Contact Lens Collaboration mddionline.com - April 7 at 6:44 PM
	J&J Vision taps Menicon for contact lenses to slow childhood nearsightedness fiercebiotech.com - April 7 at 1:44 PM
	Development and content of a database of systematic reviews for eyes and vision nature.com - April 7 at 3:24 AM
	With An Eye For Defense, Drew Valentine Takes Charge At Loyola patch.com - April 5 at 10:41 PM
	Grand National memories: Richard Pitman on Crisp v Red Rum sportinglife.com - April 5 at 12:40 PM
	Commercial drivers benefit from NRSA free eye screening ghanaweb.com - April 4 at 9:32 AM
	Why Is National Vision (EYE) Up 2.2% Since Last Earnings Report? finance.yahoo.com - April 2 at 2:00 PM
	Augusta National planned to build a ‘Ladies Course.’ Here’s what happened golf.com - April 1 at 12:20 PM
	Increased Virtual Learning Impacts Children’s Vision apnews.com - March 31 at 9:17 PM
$Sub-diffraction imaging of the human eye visualizes photoreceptors with unprecedented detail$	Sub-diffraction imaging of the human eye visualizes photoreceptors with unprecedented detail physicsworld.com - March 31 at 11:16 AM
	Can a Drug Help Prevent Diabetic Vision Loss? usnews.com - March 31 at 11:16 AM

Date	Company	Brokerage	Action
3/11/2021	The Cooper Companies	Raymond James	Boost Price Target
3/11/2021	The Cooper Companies	Citigroup	Boost Price Target
3/11/2021	The Cooper Companies	Robert W. Baird	Boost Price Target
3/11/2021	The Cooper Companies	Jefferies Financial Group	Boost Price Target
3/8/2021	The Cooper Companies	KeyCorp	Boost Price Target
2/11/2021	The Cooper Companies	Piper Sandler	Boost Price Target
1/25/2021	The Cooper Companies	Wells Fargo & Company	Boost Price Target
12/4/2020	The Cooper Companies	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	Boost Price Target
12/4/2020	The Cooper Companies	Smith Barney Citigroup	Boost Price Target
9/24/2020	The Cooper Companies	Oppenheimer	Reiterated Rating
9/4/2020	The Cooper Companies	JPMorgan Chase & Co.	Boost Price Target
9/4/2020	The Cooper Companies	Stephens	Boost Price Target
11/21/2018	Luxottica Group	HSBC	Downgrade
10/29/2018	Luxottica Group	Royal Bank of Canada	Upgrade
4/1/2021	Alcon	Berenberg Bank	Reiterated Rating
3/31/2021	Alcon	Argus	Boost Price Target
3/29/2021	Alcon	Societe Generale	Reiterated Rating
3/29/2021	Alcon	BTIG Research	Upgrade
3/3/2021	Alcon	Credit Suisse Group	Boost Price Target
3/3/2021	Alcon	Morgan Stanley	Boost Price Target
11/12/2020	Alcon	SVB Leerink	Boost Price Target
11/12/2020	Alcon	Guggenheim	Downgrade
2/25/2021	STAAR Surgical	Canaccord Genuity	Boost Price Target
1/19/2021	STAAR Surgical	Benchmark	Downgrade
10/26/2020	STAAR Surgical	Sidoti	Downgrade
1/11/2021	National Vision	Loop Capital	Downgrade
11/6/2020	National Vision	Barclays	Boost Price Target
5/8/2020	National Vision	UBS Group	Lower Price Target

(Data available from 4/19/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources